Osthole inhibits malignant phenotypes and induces ferroptosis in KRAS-mutant colorectal cancer cells via suppressing AMPK/Akt signaling
- PMID: 37318525
- DOI: 10.1007/s00280-023-04549-0
Osthole inhibits malignant phenotypes and induces ferroptosis in KRAS-mutant colorectal cancer cells via suppressing AMPK/Akt signaling
Abstract
Purpose: Ferroptosis is a form of cell death driven by iron-dependent lipid peroxidation. Intriguingly, KRAS-mutant cancers are particularly vulnerable to ferroptosis. Osthole is a natural coumarin extracted from Cnidium spp. and other Apiaceous plants. In the present study, we explored the antitumor potential of osthole in KRAS-mutant colorectal cancer (CRC) cells.
Methods: Cell viability assay, EdU incorporation assay, flow cytometry, tumor xenograft model, western blot, immunochemistry staining, immunofluorescence, transcriptome RNA sequencing and quantitative reverse transcription-PCR were performed to evaluate the influence of osthole treatment on KRAS-mutant CRC cells.
Results: We found that osthole treatment suppressed proliferation and tumor growth of KRAS-mutant CRC cell lines HCT116 and SW480. Moreover, osthole treatment increased ROS production and induced ferroptosis. Osthole treatment also promoted autophagy, but inhibition of autophagy by ATG7 knockdown or 3-MA showed no influence on osthole-induced ferroptosis. In comparison, osthole increased lysosomal activation, and co-treatment with lysosome inhibitor Baf-A1 attenuated osthole-induced ferroptosis. Besides, osthole treatment reduced the phosphorylation of AMPK, Akt and mTOR in HCT116 and SW480 cells, while restored AMPK signaling by AMPK agonist AICAR partially abrogated ferroptosis induced by osthole treatment. Finally, co-treatment with osthole increased the cytotoxicity of cetuximab in KRAS-mutant CRC cells in vitro and in vivo.
Conclusion: Our results suggested that the natural product osthole exerted its anticancer effects in KRAS-mutant CRC cells via inducing ferroptosis, and this was partially through inhibiting AMPK/Akt/mTOR signaling. Our results may expand our current knowledge for the use of osthole as an anticancer agent.
Keywords: AMPK; Colorectal cancer; Ferroptosis; KRAS; Osthole.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.Theranostics. 2020 Apr 6;10(11):5107-5119. doi: 10.7150/thno.44705. eCollection 2020. Theranostics. 2020. PMID: 32308771 Free PMC article.
-
Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer.Cell Death Dis. 2024 Jul 3;15(7):474. doi: 10.1038/s41419-024-06848-7. Cell Death Dis. 2024. PMID: 38956060 Free PMC article.
-
p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells.PLoS One. 2023 Nov 16;18(11):e0294491. doi: 10.1371/journal.pone.0294491. eCollection 2023. PLoS One. 2023. PMID: 37972012 Free PMC article.
-
Ferroptosis in colorectal cancer: a future target?Br J Cancer. 2023 Apr;128(8):1439-1451. doi: 10.1038/s41416-023-02149-6. Epub 2023 Jan 26. Br J Cancer. 2023. PMID: 36703079 Free PMC article. Review.
-
Ferroptosis: the balance between death and survival in colorectal cancer.Int J Biol Sci. 2024 Jul 2;20(10):3773-3783. doi: 10.7150/ijbs.96828. eCollection 2024. Int J Biol Sci. 2024. PMID: 39113707 Free PMC article. Review.
Cited by
-
Targeting ferroptosis regulators by natural products in colorectal cancer.Front Pharmacol. 2024 May 27;15:1374722. doi: 10.3389/fphar.2024.1374722. eCollection 2024. Front Pharmacol. 2024. PMID: 38860170 Free PMC article. Review.
-
The application of graphene oxide and ferroptosis in the diagnosis and treatment of colorectal cancer: a narrative review.J Gastrointest Oncol. 2024 Jun 30;15(3):1297-1308. doi: 10.21037/jgo-23-1016. Epub 2024 Jun 11. J Gastrointest Oncol. 2024. PMID: 38989438 Free PMC article. Review.
-
Recent progress of ferroptosis in cancers and drug discovery.Asian J Pharm Sci. 2024 Aug;19(4):100939. doi: 10.1016/j.ajps.2024.100939. Epub 2024 Jun 26. Asian J Pharm Sci. 2024. PMID: 39246507 Free PMC article. Review.
-
TCM targets ferroptosis: potential treatments for cancer.Front Pharmacol. 2024 Apr 22;15:1360030. doi: 10.3389/fphar.2024.1360030. eCollection 2024. Front Pharmacol. 2024. PMID: 38738174 Free PMC article. Review.
-
Phytochemicals regulate cancer metabolism through modulation of the AMPK/PGC-1α signaling pathway.BMC Cancer. 2024 Sep 2;24(1):1079. doi: 10.1186/s12885-024-12715-7. BMC Cancer. 2024. PMID: 39223494 Free PMC article. Review.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 71(3):209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed
-
- Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL, Siegel RL (2019) Cancer treatment and survivorship statistics, 2019. CA: Cancer J Clin. 69(5):363–385. https://doi.org/10.3322/caac.21565 - DOI - PubMed
-
- Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383(9927):1490–1502. https://doi.org/10.1016/S0140-6736(13)61649-9 - DOI - PubMed
-
- Serebriiskii IG, Connelly C, Frampton G, Newberg J, Cooke M, Miller V, Ali S, Ross JS, Handorf E, Arora S, Lieu C, Golemis EA, Meyer JE (2019) Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. Nat Commun 10(1):3722. https://doi.org/10.1038/s41467-019-11530-0 - DOI - PubMed - PMC
-
- Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J (2012) Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci 13(10):12153–12168. https://doi.org/10.3390/ijms131012153 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous